Gritstone Bio Inc (GRTS)
0.7608
+0.01
(+1.93%)
USD |
NASDAQ |
May 31, 16:00
0.76
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Enterprise Value: 76.63M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 76.63M |
| May 30, 2024 | 75.06M |
| May 29, 2024 | 77.72M |
| May 28, 2024 | 80.88M |
| May 24, 2024 | 81.06M |
| May 23, 2024 | 83.30M |
| May 22, 2024 | 85.45M |
| May 21, 2024 | 84.07M |
| May 20, 2024 | 82.83M |
| May 17, 2024 | 79.51M |
| May 16, 2024 | 75.08M |
| May 15, 2024 | 75.45M |
| May 14, 2024 | 76.68M |
| May 13, 2024 | 77.61M |
| May 10, 2024 | 79.20M |
| May 09, 2024 | 99.64M |
| May 08, 2024 | 100.83M |
| May 07, 2024 | 103.68M |
| May 06, 2024 | 98.45M |
| May 03, 2024 | 97.16M |
| May 02, 2024 | 87.23M |
| May 01, 2024 | 87.63M |
| April 30, 2024 | 79.73M |
| April 29, 2024 | 80.39M |
| April 26, 2024 | 81.17M |
| Date | Value |
|---|---|
| April 25, 2024 | 75.93M |
| April 24, 2024 | 81.11M |
| April 23, 2024 | 73.15M |
| April 22, 2024 | 73.89M |
| April 19, 2024 | 72.40M |
| April 18, 2024 | 73.16M |
| April 17, 2024 | 73.32M |
| April 16, 2024 | 76.16M |
| April 15, 2024 | 72.65M |
| April 12, 2024 | 83.52M |
| April 11, 2024 | 92.14M |
| April 10, 2024 | 94.71M |
| April 09, 2024 | 98.16M |
| April 08, 2024 | 101.49M |
| April 05, 2024 | 97.26M |
| April 04, 2024 | 104.15M |
| April 03, 2024 | 110.78M |
| April 02, 2024 | 111.76M |
| April 01, 2024 | 224.60M |
| March 31, 2024 | 246.18M |
| March 28, 2024 | 212.90M |
| March 27, 2024 | 235.45M |
| March 26, 2024 | 214.86M |
| March 25, 2024 | 224.67M |
| March 22, 2024 | 229.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-43.28M
Minimum
May 25 2022
1.118B
Maximum
Jan 22 2021
171.34M
Average
134.99M
Median
Enterprise Value Benchmarks
| Precision BioSciences Inc | -25.90M |
| Humacyte Inc | 774.06M |
| Verastem Inc | 52.61M |
| BioVie Inc | 4.933M |
| Adial Pharmaceuticals Inc | 1.071M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -40.38M |
| Revenue (Quarterly) | 0.049M |
| Total Expenses (Quarterly) | 39.85M |
| EPS Diluted (Quarterly) | -0.34 |
| Profit Margin (Quarterly) | -82.42K% |
| Earnings Yield | -163.0% |
| Normalized Earnings Yield | -162.99 |